Vaccines for melanoma. Design strategies and clinical results.
Melanoma vaccines represent a novel and potentially effective method of slowing the progression of melanoma. This article discusses the importance in the design of vaccines for melanoma, the relative advantages and disadvantages of this approach, and summarizes the results of the most important clinical trials conducted to date with this vaccine.
Bystryn
J C
JC
Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, USA.
D019496:Cancer Vaccines / Q000008:administration & dosage* / Q000494:pharmacology; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D007114:Immunization; D008545:Melanoma / Q000276:immunology / Q000517:prevention & control*; D012878:Skin Neoplasms / Q000276:immunology / Q000517:prevention & control*
D019496:Cancer Vaccines